Related Experiment Videos
Branched biodegradable polyesters for parenteral drug delivery systems
A Breitenbach1, Y X Li, T Kissel
1Department of Pharmaceutics and Biopharmacy, Philipps University, Ketzerbach 63, D-35037, Marburg, Germany.
Summary
Developing novel branched biodegradable polyesters, including star-shaped and brush-like structures, improves protein drug delivery. These advanced materials offer tailored properties for sustained release from parenteral systems.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Drug Delivery Systems
Background:
- Achieving continuous drug release from biodegradable parenteral systems for hydrophilic macromolecules like proteins is challenging with linear polyesters (PLA, PLG).
- Modifying polyester hydrophilicity or polymer architecture is key to controlling degradation and drug release rates.
Purpose of the Study:
- To investigate novel branched polymer architectures for biodegradable polyesters.
- To enhance protein delivery from parenteral systems using tailored polymer properties.
Main Methods:
- Synthesized star-branched polyesters by grafting poly(ethylene oxide) (PEO) onto multi-arm PEO cores.
- Created comb-like polyesters using dextrans or poly(vinyl alcohol) (PVA) as hydrophilic backbones.
- Characterized polymers using NMR, IR, SEC-SLS, DSC, and viscosity measurements.
Main Results:
- Star-branched polyesters exhibited unique degradation behavior, retaining PEO blocks longer than ABA triblock copolymers, but required further optimization for release profiles.
- Brush-like branched polyesters demonstrated promising degradation and release properties suitable for parenteral protein delivery.
- Characterization confirmed tailor-made properties of the novel branched polyesters.
Conclusions:
- Branched biodegradable polyesters, particularly brush-like structures, are promising for parenteral protein delivery systems.
- Further investigation into brush-like branched polyesters is warranted due to their favorable degradation and release characteristics.
- Optimized polymer architecture is crucial for achieving desired drug release profiles in parenteral applications.